Bain Capital Life Sciences Investors as of June 30, 2026
Portfolio Holdings for Bain Capital Life Sciences Investors
Bain Capital Life Sciences Investors holds 21 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kailera Therapeutics Common Stock | 29.6 | $498M | 23M | 22.03 | |
| Heartflow Inc/Sh (HTFL) | 14.7 | $248M | 8.4M | 29.34 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 7.7 | $129M | 3.8M | 33.89 | |
| Savara (SVRA) | 6.4 | $108M | 18M | 6.16 | |
| Alkermes SHS (ALKS) | 6.0 | $102M | 1.9M | 52.40 | |
| Solid Biosciences Com New (SLDB) | 5.8 | $98M | 9.8M | 9.99 | |
| Pharvaris N V (PHVS) | 5.5 | $93M | 2.7M | 34.58 | |
| Olema Pharmaceuticals (OLMA) | 5.3 | $89M | 7.1M | 12.51 | |
| Hemab Therapeutics Holdings Com Shs | 3.6 | $61M | 1.7M | 36.73 | |
| Cabaletta Bio (CABA) | 3.2 | $54M | 17M | 3.11 | |
| X4 Pharmaceuticals Com New (XFOR) | 2.2 | $37M | 8.0M | 4.67 | |
| Dianthus Therapeutics (DNTH) | 2.1 | $35M | 363k | 97.48 | |
| C4 Therapeutics Com Stk (CCCC) | 2.0 | $34M | 7.2M | 4.67 | |
| Kyverna Therapeutics (KYTX) | 1.5 | $26M | 2.9M | 8.91 | |
| Annexon (ANNX) | 1.5 | $25M | 4.4M | 5.71 | |
| Rapid Micro Biosystems Class A Com (RPID) | 0.9 | $15M | 8.4M | 1.73 | |
| Disc Medicine (IRON) | 0.6 | $10M | 141k | 73.14 | |
| Atea Pharmaceuticals (AVIR) | 0.6 | $9.7M | 2.1M | 4.65 | |
| Xilio Therapeutics (XLO) | 0.4 | $6.4M | 664k | 9.58 | |
| Upstream Bio (UPB) | 0.2 | $4.2M | 601k | 6.92 | |
| Newamsterdam Pharma Company *w Exp 99/99/999 (NAMSW) | 0.1 | $2.1M | 100k | 21.37 |
